Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 11/20 | 0.64 |
| ▸ | CNR2 | P34972 | 8/20 | 0.64 |
| ▸ | HTR4 | Q13639 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HTR3A | P46098 | 1/20 | 0.47 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13691257 | 0.91 | CNR1 (0.57) | CNR1CNR2HTR4CYP3A4HTR3A | |
| SCHEMBL4053133 | 0.91 | CNR1 (0.57) | CNR1CNR2HTR4CYP3A4HTR3A | |
| SCHEMBL29993194 | 0.90 | CNR1 (0.77) | CNR1CNR2HTR4HTR3AROCK2 | |
| SCHEMBL30473233 | 0.90 | CNR1 (0.77) | CNR1CNR2HTR4HTR3AROCK2 | |
| SCHEMBL4053063 | 0.90 | CNR1 (0.77) | CNR1CNR2HTR4HTR3AROCK2 | |
| SCHEMBL4050197 | 0.90 | CNR1 (0.55) | CNR1CNR2HTR4CYP3A4HTR3A | |
| SCHEMBL4048720 | 0.89 | CNR1 (0.56) | CNR1CNR2HTR4CYP3A4HTR3A | |
| SCHEMBL13691040 | 0.89 | CNR1 (0.64) | CNR1CNR2HTR4HTR3AROCK2 | |
| SCHEMBL4056764 | 0.88 | CNR1 (0.49) | CNR1CNR2HTR4CYP3A4ROCK1 | |
| SCHEMBL13690992 | 0.88 | CNR1 (0.49) | CNR1CNR2HTR4CYP3A4ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009106980-A2 | INDAZOLE DERIVATIVES | PFIZER INC. (US) | 2009-09-03 | — | — | WO | claimed |
| WO-2009106980-A2 | INDAZOLE DERIVATIVES | PFIZER INC. (US) | 2009-09-03 | — | — | WO | disclosed |